HALPERN JOHN D 13D/13G Filings for Eterna Therapeutics Inc. (ERNA)

HALPERN JOHN D 13D and 13G filings for Eterna Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
8:36 pm
Purchase
2024-10-29 13G Eterna Therapeutics Inc.
ERNA
HALPERN JOHN D 5,136,581
9.990%
5,136,581increase
(New Position)
Filing